MyGene

What MyGene does

Genekang, operating under the brand MyGene and the sub-brand Lecheng Care OS, runs a web-based biomedical healthcare navigation platform anchored to the Lecheng (Hainan Boao) medical tourism zone in China. The platform serves two primary user groups: medical tourism patients seeking care in the Lecheng zone who need help organizing examination records and understanding screening eligibility, and registered physicians who need a structured intake channel for those patients. Its core product, Lecheng Care OS, consists of a patient registration module, a doctor registration module, mobile/SMS-based authentication, a data organization feature for uploading medical records, a rule-based preliminary screening engine that flags missing information and directs cases for manual review, and a report/follow-up notification layer. Technically, the system is built around deterministic rule logic rather than AI/ML — the platform explicitly states it provides decision support only and does not constitute diagnosis or treatment.

Revenue mechanics are not disclosed in the available source material. There is no publicly stated pricing model, no disclosed fee per patient or per doctor, no enterprise contract evidence, and no headcount data. The company is privately held under the Genekang legal entity (Beijing-domiciled per ICP filing 京ICP备14047766号-1), with no venture capital, private equity, or institutional investor involvement evidenced, and no funding rounds on record since founding in 2014. Distribution is direct via mygene.com through patient and doctor self-registration pathways, with no marketing channels, partnerships, or channel partners identified. The operating footprint is restricted to the Lecheng medical zone ecosystem, with no disclosed expansion to other geographies or verticals.

Name

MyGene

Legal name

Genekang

Website

https://mygene.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

MyGene (Genekang) operates Lecheng Care OS, a web-based platform that helps medical tourism patients in China's Lecheng (Hainan Boao) zone organize medical records, complete rule-based preliminary screening, and connect with registered doctors.

Ownership category

akta.pro rank

Product category

Healthcare Decision Support Software

NAICS

Computer Systems Design Services (541512)

SIC

Services-Health Services (8000), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

• Medical record management
• Patient screening software
• Medical tourism platform
• Healthcare decision support
• Biomedical navigation tools

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Operations, Personnel, Infrastructure, Marketing or Sales

Core offering

MyGene operates Lecheng Care OS, a web-based healthcare navigation platform that helps patients organize medical examination records, complete rule-based preliminary screening, and connect with doctors and Lecheng (Hainan Boao) medical zone services. The platform provides patient and doctor registration, mobile-based login authentication, record upload and management, report viewing, and follow-up notifications. It is positioned strictly as decision support and does not provide diagnosis or treatment.

Product overview

MyGene operates Lecheng Care OS, a unified biomedical healthcare navigation platform designed to assist patients in organizing medical records, conducting rule-based preliminary screening, and connecting with doctors and Lecheng-related medical services. The platform includes patient-facing features for data upload and management, report viewing, and notification reception; doctor-facing registration and patient management capabilities; and an authentication system with mobile phone login and password recovery. The system explicitly states it is for decision support only and does not constitute diagnosis or treatment advice.

Differentiator

Problem solved

Functional benefit

Brands

• Lecheng Care OS: Healthcare navigation system for patient data management, preliminary screening, and connecting patients with doctors and medical services.

Products and services

• Lecheng Care OS A biomedical new technology navigator system that assists patients in organizing medical records, completing rule-based preliminary screening, and connecting with doctors and Lecheng-related medical services. Includes patient registration, doctor registration, login authentication, password recovery, mobile record upload, screening prompts, and report and follow-up notifications. Designed for medical tourism patients at the Lecheng (Hainan Boao) medical zone and licensed physicians serving them. Positioned as decision support only — not a diagnostic or treatment service.

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Recent moves2 records

Direct peers

• WeDoctor (微医): WeDoctor operates one of China's largest patient navigation and telemedicine platforms, connecting patients with doctors through structured pre-consultation, appointment booking, and follow-up workflows. It is comparable to MyGene in providing patient-doctor connection and pre-consultation organization, but at materially larger scale and broader scope.
• Chunyu Doctor (春雨医生): Chunyu Doctor is a long-running Chinese mobile-first platform for online patient-doctor consultation, with built-in patient record capture and symptom triage. It is comparable to MyGene in emphasizing mobile patient onboarding and pre-consultation information gathering, but operates at much greater national scale.
• Hao Daifu Online (好大夫在线): Hao Daifu Online is a Chinese doctor-patient platform providing appointment booking, pre-consultation patient information capture, and follow-up services. It is comparable to MyGene in structuring patient data prior to clinical interaction and connecting that data to the consulting physician.
• DXY (丁香园): DXY is one of China's largest healthcare professional communities with patient-facing tools for finding doctors, organizing medical records, and pre-consultation information structuring. It is comparable to MyGene in providing structured patient data capture and physician connection, though across a much broader medical specialty range.
• Medlinker (医联): Medlinker is a Chinese physician collaboration platform with patient management and follow-up tools. It is comparable to MyGene in providing physician-facing onboarding and patient workflow tooling, though Medlinker emphasizes physician peer collaboration rather than patient-side medical-tourism navigation.

Broad incumbents

• Ping An Healthcare and Technology (平安健康): Ping An Healthcare operates a massive integrated Chinese health platform offering telemedicine, patient navigation, insurance integration, and chronic-disease management. It is comparable to MyGene as a broad Chinese patient-engagement platform, but operates at vastly larger scale and with overlapping capabilities MyGene would face as competition.
• JD Health (京东健康): JD Health is the healthcare arm of JD.com, combining pharmaceutical e-commerce with online consultation and patient services. It is comparable to MyGene as a Chinese platform offering patient-doctor connection and medical information services, but at dramatically larger scale and as part of a much wider commerce-driven offering.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MyGene